NanoVibronix, Inc. (NAOV): Market Value

NanoVibronix, Inc. (NAOV) develops digitally controlled mobile ultrasound systems for automated wound healing, and this market dynamics, reflected in the price action, is currently at 0.00. The company relies on contract electronics manufacturing and outsourced clinical trial management. The UroShield product line for combating infections in hospital and home settings confirms the business's transition into an active sales scaling phase.

NAOV (nanovibronix.com) Market Value history from 07/04/2022 to 12/12/2025

Comprehensive metric breakdowns and analytics for NanoVibronix, Inc. (NAOV)

- current price and projected stock value:

Stock Price NanoVibronix Inc.|NAOV - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value NanoVibronix, Inc.|NAOV - Total Enterprise Value

- book value of equity indicators:

Accounting Value per Share NanoVibronix|NAOV - Company Book Value|Market Cap to Net Assets Ratio nanovibronix.com|NAOV - Aggregate Business Assets

- debt and liquidity data:

- net income and valuation multiples indicators:

NAOV - Profit After Tax|Projected Future Earnings NanoVibronix, Inc.|NAOV - Market Cap to Earnings|Projected Price to Earnings NanoVibronix Inc.|NAOV - PEG Multiple|Enterprise Value to EBITDA Ratio NanoVibronix, Inc.|NAOV - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) NanoVibronix|NAOV - Net earnings per share for the last four quarters|Quarterly EPS earnings growth nanovibronix.com|NAOV - Net earnings per share growth this year|Expected earnings per share growth for next year NanoVibronix, Inc.

- sales revenue and business income indicators:

NAOV - Company Sales Revenue|Company Projected Revenue NanoVibronix Inc.|NAOV - Market Cap to Revenue|Forward P/S Multiple NanoVibronix, Inc.|NAOV - Trailing Twelve Months Revenue Growth

Initial company analysis:NAOV (NanoVibronix)

NanoVibronix, Inc. (NAOV) specializes in innovative acoustic devices for tissue regeneration. Market capitalization is calculated as the product of the current share price and the total number of issued securities. This metric determines the aggregate volume of capital that the market is willing to invest in the company's business model. The dynamics of the company's total market value allow investors to filter out market noise and identify the real valuation trend. Analyzing this line helps an investor distinguish temporary undervaluation from a systemic impairment of assets.

Key competitors